These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7446744)

  • 1. Clearance of circulating anionic and cationic pancreatic trypsinogens in the rat.
    Brodrick JW; Largman C; Geokas MC; O'Rourke M; Ray SB
    Am J Physiol; 1980 Dec; 239(6):G511-5. PubMed ID: 7446744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma pancreatic trypsinogens in chronic renal failure and after nephrectomy.
    Geokas MC; Reidelberger R; O'Rourke M; Passaro E; Largman C
    Am J Physiol; 1982 Feb; 242(2):G177-82. PubMed ID: 7065144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clearance and metabolism of circulating pancreatic proelastase in the rat.
    Largman C; Ray SB; Brodrick JW; Geokas MC
    Am J Physiol; 1980 Dec; 239(6):G504-10. PubMed ID: 6905671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of a cDNA encoding rat cationic trypsinogen.
    Fletcher TS; Alhadeff M; Craik CS; Largman C
    Biochemistry; 1987 Jun; 26(11):3081-6. PubMed ID: 3607011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term nicotine exposure causes increased concentrations of trypsinogens and amylase in pancreatic extracts in the rat.
    Lindkvist B; Wierup N; Sundler F; Borgström A
    Pancreas; 2008 Oct; 37(3):288-94. PubMed ID: 18815551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesotrypsin: a new inhibitor-resistant protease from a zymogen in human pancreatic tissue and fluid.
    Rinderknecht H; Renner IG; Abramson SB; Carmack C
    Gastroenterology; 1984 Apr; 86(4):681-92. PubMed ID: 6698368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of human pancreatic cationic trypsinogen in serum by radioimmunoassay.
    Geokas MC; Largman C; Brodrick JW; Johnson JH
    Am J Physiol; 1979 Jan; 236(1):E77-83. PubMed ID: 434151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The two human trypsinogens. Evidence of complex formation with basic pancreatic trypsin inhibitor-proteolytic activity.
    Colomb E; Figarella C; Guy O
    Biochim Biophys Acta; 1979 Oct; 570(2):397-405. PubMed ID: 40607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalities of circulating immunoreactive pancreatic anionic trypsinogen in cystic fibrosis: an assay artifact due to cross-reacting serum antibodies.
    Moore DJ; Largman C; Kopelman HR; Wong S; Durie PR
    Clin Biochem; 1986 Oct; 19(5):303-7. PubMed ID: 3769196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human anionic trypsinogen: properties of autocatalytic activation and degradation and implications in pancreatic diseases.
    Kukor Z; Tóth M; Sahin-Tóth M
    Eur J Biochem; 2003 May; 270(9):2047-58. PubMed ID: 12709065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fate of intravenously injected trypsinogens in dogs.
    Borgström A
    Scand J Gastroenterol; 1981; 16(2):281-7. PubMed ID: 7313540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anionic and cationic dog trypsin. Isolation and partial characterization.
    Ohlsson K; Tegner H
    Biochim Biophys Acta; 1973 Aug; 317(2):328-37. PubMed ID: 19999718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A possible zymogen self-destruct mechanism preventing pancreatic autodigestion.
    Rinderknecht H; Adham NF; Renner IG; Carmack C
    Int J Pancreatol; 1988; 3(1):33-44. PubMed ID: 3162506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible lysosomal activation of pancreatic zymogens. Activation of both human trypsinogens by cathepsin B and spontaneous acid. Activation of human trypsinogen 1.
    Figarella C; Miszczuk-Jamska B; Barrett AJ
    Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():293-8. PubMed ID: 3202969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Purificatio of trypsinogens and chymotrypsinogen from rat pancreas].
    Vandermeers A; Christophe J
    Arch Int Physiol Biochim; 1969 Aug; 77(3):577-8. PubMed ID: 4186398
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of two major proteins of bovine pancreatic stones as immunoreactive forms of trypsinogens.
    De Caro A; Multigner L; Vérine H
    Biochem J; 1982 Sep; 205(3):543-9. PubMed ID: 7150231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active site in zymogens. Proton magnetic resonance pH titration curves of histidine-57 in porcine and bovine trypsinogens and in their complexes with bovine pancreatic trypsin inhibitor (Kunitz).
    Porubcan MA; Neves DE; Rausch SK; Markley JL
    Biochemistry; 1978 Oct; 17(22):4640-7. PubMed ID: 31899
    [No Abstract]   [Full Text] [Related]  

  • 18. Mass spectrometric detection of tyrosine sulfation in human pancreatic trypsinogens, but not in tumor-associated trypsinogen.
    Itkonen O; Helin J; Saarinen J; Kalkkinen N; Ivanov KI; Stenman UH; Valmu L
    FEBS J; 2008 Jan; 275(2):289-301. PubMed ID: 18076654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human trypsinogens in the pancreas and in cancer.
    Itkonen O
    Scand J Clin Lab Invest; 2010 Apr; 70(2):136-43. PubMed ID: 20163205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma disappearance of homologous and heterologous pancreatic enzymes in dogs.
    Hayakawa T; Kondo T; Shibata T; Kitagawa M; Naruse S
    J Gastroenterol Hepatol; 1992; 7(5):527-32. PubMed ID: 1382659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.